Mathias Dreger

Identification of orcokinins in single neurons in the stomatogastric nervous system of the crayfish, Cherax destructor.

Activation by acidic pH of CLC-7 expressed in oocytes from Xenopus laevis.

Global role for ClpP-containing proteases in stationary-phase adaptation of Escherichia coli.

Emerging strategies in mass-spectrometry based proteomics.

Proteome analysis at the level of subcellular structures.

Subcellular proteomics.

Dual expression of mouse and rat VRL-1 in the dorsal root ganglion derived cell line F-11 and biochemical analysis of VRL-1 after heterologous expression.

The nuclear envelope proteome.

Identification of versican as an isolectin B4-binding glycoprotein from mammalian spinal cord tissue.

Analysis of the dorsal spinal cord synaptic architecture by combined proteome analysis and in situ hybridization.

Studies of the ATPase activity of the ABC protein SUR1.

Immunocapture and identification of cell membrane protein antigenic targets of serum autoantibodies.

A quantitative strategy to detect changes in accessibility of protein regions to chemical modification on heterodimerization.

Jmjd6 catalyses lysyl-hydroxylation of U2AF65, a protein associated with RNA splicing.

The cAMP capture compound mass spectrometry as a novel tool for targeting cAMP-binding proteins: from protein kinase A to potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channels.

Capture compound mass spectrometry sheds light on the molecular mechanisms of liver toxicity of two Parkinson drugs.

GDP-capture compound--a novel tool for the profiling of GTPases in pro- and eukaryotes by capture compound mass spectrometry (CCMS).

Comprehensive identification of staurosporine-binding kinases in the hepatocyte cell line HepG2 using Capture Compound Mass Spectrometry (CCMS).

Differential expression level of cytokeratin 8 in cells of the bovine nucleus pulposus complicates the search for specific intervertebral disc cell markers.

Are meaningful predictions of toxicological outcomes in clinical trials based on in vitro diagnostics of preclinical drug candidates possible?

Dasatinib, imatinib and staurosporine capture compounds - Complementary tools for the profiling of kinases by Capture Compound Mass Spectrometry (CCMS).

Probing small molecule-protein interactions: A new perspective for functional proteomics.

SAHA Capture Compound--a novel tool for the profiling of histone deacetylases and the identification of additional vorinostat binders.

Improvement of capture compound mass spectrometry technology (CCMS) for the profiling of human kinases by combination with 2D LC-MS/MS.

Proteome-wide identification of staurosporine-binding kinases using capture compound mass spectrometry.

Profiling of methyltransferases and other S-Adenosyl-L-homocysteine-binding proteins by Capture Compound mass spectrometry.

Light-triggered conversion of non-ionic into ionic surfactants: towards chameleon detergents for 2-D gel electrophoresis.